Radx tech - ceres nanoscience INC nanotrap particle manufacturing
Ended Definitive Contract Awarded Last action
- Contract number
- 75N92020C00021
- Awardee
-
Ceres Nanosciences, Inc. UEI GL6HXTK992Y4
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $6,574,000
Award facts
- Contract value 100% obligated
- $6,574,000.00 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Manassas, VA 20110, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Definitize Letter Contract | $3,974,000 | |
| Original award | $2,600,000 |
About this award
Ceres Nanosciences, Inc. was awarded a definitive contract valued at $6.57 million by the National Heart, Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to support the Rapid Acceleration of Diagnostics (RADx) initiative. The firm fixed price contract calls for Ceres Nanosciences to provide nanotrap particle manufacturing in Manassas, Virginia over a one year period ending August 2022. No subcontractors or set aside designations were identified. The RADx program aims to speed innovation in the development, commercialization, and implementation of technologies for COVID-19 testing. This award will support those efforts through Ceres Nanosciences' nanoparticle production to advance diagnostic capabilities.
Quick answers
Who was awarded contract 75N92020C00021?
75N92020C00021 was awarded to Ceres Nanosciences, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on August 28, 2020.
How much is contract 75N92020C00021 worth?
The government has obligated $6,574,000 on 75N92020C00021.
Was contract 75N92020C00021 competed?
The extent of competition for 75N92020C00021 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award